We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B Turnover 6.98%
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$93.3M
Cap. Flow
-$7.51M
Cap. Flow %
-0.58%
Top 10 Hldgs %
25.17%
Holding
390
New
85
Increased
121
Reduced
146
Closed
8
Avg Time Held
3.4 years
Top 10 Avg Time Held
2.6 years
Top 20 Avg Time Held
2.9 years

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.53M
2
DOCU icon
DocuSign
DOCU
+$1.16M
3
AAPL icon
Apple
AAPL
+$971K
4
MZTI icon
The Marzetti Company
MZTI
+$858K
5
MSFT icon
Microsoft
MSFT
+$723K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.98%
2 Technology 14.73%
3 Healthcare 13.63%
4 Financials 11.39%
5 Consumer Staples 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
INTC icon
26
Intel
INTC
$504B
$11.1M 0.85%
185,191
-3,112
-2% -$174K
2013 Q2
26 quarters
CMCSA icon
27
Comcast
CMCSA
$77.3B
$11.1M 0.85%
246,280
+198
+0.1% +$8.81K
2013 Q2
26 quarters
DXCM icon
28
DexCom
DXCM
$33.1B
$10.7M 0.82%
195,636
-9,984
-5% -$474K
2014 Q1
23 quarters
IBB icon
29
iShares Biotechnology ETF
IBB
$10.6B
$10.5M 0.81%
87,088
-1,440
-2% -$161K
2013 Q2
26 quarters
BAC icon
30
Bank of America
BAC
$362B
$10.5M 0.8%
297,481
-1,221
-0.4% -$39.5K
2019 Q2
2 quarters
SBUX icon
31
Starbucks
SBUX
$110B
$10.1M 0.78%
115,053
-1,473
-1% -$126K
2013 Q2
26 quarters
SCZ icon
32
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.7B
$9.8M 0.75%
157,432
-540
-0.3% -$32.4K
2013 Q2
26 quarters
IJT icon
33
iShares S&P Small-Cap 600 Growth ETF
IJT
$7.57B
$9.73M 0.75%
100,724
-1,054
-1% -$97.3K
2013 Q2
26 quarters
RTN
34
DELISTED
Raytheon Company
RTN
$9.55M 0.73%
43,473
-639
-1% -$135K
2017 Q1
11 quarters
MRK icon
35
Merck
MRK
$358B
$9.33M 0.72%
107,527
-2,713
-2% -$223K
2013 Q2
26 quarters
CSCO icon
36
Cisco
CSCO
$433B
$9.31M 0.71%
194,040
-903
-0.5% -$42K
2013 Q2
26 quarters
MCD icon
37
McDonald's
MCD
$172B
$9.2M 0.71%
46,542
-680
-1% -$135K
2013 Q2
26 quarters
VFH icon
38
Vanguard Financials ETF
VFH
$13.1B
$8.81M 0.68%
115,544
-3,895
-3% -$284K
2013 Q2
26 quarters
HON icon
39
Honeywell
HON
$66.7B
$8.64M 0.66%
51,800
-1,106
-2% -$181K
2013 Q2
26 quarters
UNP icon
40
Union Pacific
UNP
$172B
$8.62M 0.66%
47,678
-107
-0.2% -$18.3K
2013 Q2
26 quarters
PG icon
41
Procter & Gamble
PG
$365B
$8.55M 0.66%
68,486
-1,594
-2% -$195K
2013 Q2
26 quarters
AXP icon
42
American Express
AXP
$212B
$8.52M 0.65%
68,441
-1,220
-2% -$146K
2019 Q2
2 quarters
AMGN icon
43
Amgen
AMGN
$235B
$8.33M 0.64%
34,558
+212
+0.6% +$46.7K
2019 Q2
2 quarters
VOX icon
44
Vanguard Communication Services ETF
VOX
$6.11B
$8.3M 0.64%
88,344
-1,645
-2% -$149K
2013 Q2
26 quarters
META icon
45
Meta Platforms (Facebook)
META
$1.88T
$8.23M 0.63%
40,119
-1,468
-4% -$284K
2013 Q2
26 quarters
PYPL icon
46
PayPal
PYPL
$48.9B
$8.22M 0.63%
76,035
+708
+0.9% +$73.8K
2015 Q3
17 quarters
TXN icon
47
Texas Instruments
TXN
$255B
$7.98M 0.61%
62,190
+516
+0.8% +$63.7K
2019 Q1
3 quarters
LLY icon
48
Eli Lilly
LLY
$1.12T
$7.96M 0.61%
60,548
-159
-0.3% -$18.4K
2013 Q2
26 quarters
PEP icon
49
PepsiCo
PEP
$175B
$7.95M 0.61%
58,200
-500
-0.9% -$68K
2013 Q2
26 quarters
CVX icon
50
Chevron
CVX
$430B
$7.92M 0.61%
65,737
-3,115
-5% -$367K
2013 Q2
26 quarters

Similar funds

Dowling & Yahnke's Q4 2019 Portfolio in Review

As of Q4 2019, Dowling & Yahnke held 390 positions worth $1.3B, up 7.7% from $1.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dowling & Yahnke's Q4 2019 filing shows 85 new, 121 increased, 146 reduced and 8 closed positions. Its largest new stake was iShares National Muni Bond ETF: 4,701 shares worth $535K. The largest sale was Celgene Corp, an estimated $2.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q4 2019 buy was iShares National Muni Bond ETF: 4,701 shares worth $535K.
  • Dowling & Yahnke added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.6M increase.
  • Dowling & Yahnke's biggest Q4 2019 reduction was DocuSign, cutting an estimated $1.16M.
  • Dowling & Yahnke fully exited Celgene Corp in Q4 2019, selling an estimated $2.53M.
  • Dowling & Yahnke's ten largest holdings make up 25% of its $1.3B portfolio in Q4 2019.
  • Dowling & Yahnke opened 85 new positions and closed 8 in Q4 2019.
  • Dowling & Yahnke's portfolio value rose 7.7% quarter-over-quarter to $1.3B.

Based on Dowling & Yahnke's 13F filing for Q4 2019, filed 27 Jan 2020.